Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_assertion wasGeneratedBy ECO_0000203 NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_assertion wasDerivedFrom befree-20140225 NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_assertion SIO_000772 22135462 NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_assertion evidence source_evidence_literature NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_assertion description "[Expression of Kirsten rat sarcoma viral oncogene [Kras(G12V)] and disruption of cyclin-dependent kinase inhibitor 2A (CDKN2A; p16p19) in prospectively isolated satellite cells gave rise to pleomorphic rhabdomyosarcomas (MyoD-, Myogenin- and Desmin-positive), whereas introduction of the same oncogenetic hits in nonmyogenic progenitors induced pleomorphic sarcomas lacking myogenic features.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.
- befree-20140225 importedOn "2014-02-25" NP816118.RA0d66dn7IE2QjCxU8HALlxXnWOTrOdDhOLqScwp9KvjA130_provenance.